Biochemical Markers in the Prediction of Contrast-induced Acute Kidney Injury

Author(s): Magdalena Zdziechowska, Anna Gluba-Brzózka*, Beata Franczyk, Jacek Rysz

Journal Name: Current Medicinal Chemistry

Volume 28 , Issue 6 , 2021


  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Abstract:

For many years clinicians have been searching for “kidney troponin”- a simple diagnostic tool to assess the risk of acute kidney injury (AKI). Recently, the rise in the variety of contrast-related procedures (contrast computed tomography (CT), percutaneous coronary intervention (PCI) and angiography) has resulted in the increased number of contrast-induced acute kidney injuries (CI-AKI). CIAKI remains an important cause of overall mortality, prolonged hospitalisation and it increases the total costs of therapy. The consequences of kidney dysfunction affect the quality of life and they may lead to disability as well. Despite extensive worldwide research, there are no sensitive and reliable methods of CI-AKI prediction. Kidney Injury Molecule 1 (KIM-1) and Neutrophil Gelatinase Lipocalin (NGAL) have been considered as kidney-specific molecules. High concentrations of these substances before the implementation of contrast-related procedures have been suggested to enable the estimation of kidney vulnerability to CI-AKI and they seem to have the predictive potential for cardiovascular events and overall mortality. According to other authors, routine determination of known inflammation factors (e.g., CRP, WBC, and neutrophil count) may be helpful in the prediction of CIAKI. However, the results of clinical trials provide contrasting results. The pathomechanism of contrast- induced nephropathy remains unclear. Due to its prevalence, the evaluation of the risk of acute kidney injury remains a serious problem to be solved. This paper reviews pathophysiology and suggested optimal markers facilitating the prediction of contrast-induced acute kidney injury.

Keywords: Contrast-induced acute kidney injury, contrast CT, percutaneous coronary angioplasty, Kidney Injury Molecule 1 (KIM-1), Neutrophil Gelatinase Lipocalin (NGAL), Percutaneous Coronary Intervention (PCI).

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 28
ISSUE: 6
Year: 2021
Published on: 01 May, 2020
Page: [1234 - 1250]
Pages: 17
DOI: 10.2174/0929867327666200502015749
Price: $65

Article Metrics

PDF: 153